1.37
|
2.52e-20
|
GO:0007399
|
nervous system development
|
1.13
|
9.16e-20
|
GO:0050789
|
regulation of biological process
|
1.14
|
1.00e-19
|
GO:0050794
|
regulation of cellular process
|
1.12
|
2.02e-19
|
GO:0065007
|
biological regulation
|
1.23
|
8.07e-17
|
GO:0048731
|
system development
|
1.43
|
2.86e-16
|
GO:0022008
|
neurogenesis
|
1.33
|
3.65e-16
|
GO:0009653
|
anatomical structure morphogenesis
|
1.21
|
1.27e-15
|
GO:0048856
|
anatomical structure development
|
1.07
|
1.51e-15
|
GO:0009987
|
cellular process
|
1.23
|
1.55e-15
|
GO:0048518
|
positive regulation of biological process
|
1.24
|
6.11e-15
|
GO:0048522
|
positive regulation of cellular process
|
1.19
|
9.02e-15
|
GO:0007275
|
multicellular organismal development
|
1.42
|
2.76e-14
|
GO:0048699
|
generation of neurons
|
1.18
|
1.07e-13
|
GO:0023052
|
signaling
|
1.18
|
2.61e-13
|
GO:0032502
|
developmental process
|
1.25
|
6.67e-13
|
GO:0030154
|
cell differentiation
|
1.44
|
2.20e-12
|
GO:0030182
|
neuron differentiation
|
1.24
|
6.19e-12
|
GO:0048869
|
cellular developmental process
|
1.22
|
1.51e-11
|
GO:0048519
|
negative regulation of biological process
|
1.36
|
2.92e-11
|
GO:0048468
|
cell development
|
1.23
|
4.41e-11
|
GO:0048523
|
negative regulation of cellular process
|
1.16
|
2.26e-10
|
GO:0031323
|
regulation of cellular metabolic process
|
1.17
|
3.82e-10
|
GO:0007165
|
signal transduction
|
1.33
|
1.31e-09
|
GO:0006357
|
regulation of transcription from RNA polymerase II promoter
|
1.25
|
3.40e-09
|
GO:0023051
|
regulation of signaling
|
1.35
|
5.69e-09
|
GO:0051128
|
regulation of cellular component organization
|
1.45
|
5.85e-09
|
GO:0000904
|
cell morphogenesis involved in differentiation
|
1.15
|
6.73e-09
|
GO:0080090
|
regulation of primary metabolic process
|
1.33
|
9.77e-09
|
GO:0031324
|
negative regulation of cellular metabolic process
|
1.26
|
1.08e-08
|
GO:0009966
|
regulation of signal transduction
|
1.42
|
1.38e-08
|
GO:0048666
|
neuron development
|
1.39
|
2.19e-08
|
GO:0007167
|
enzyme linked receptor protein signaling pathway
|
1.22
|
2.47e-08
|
GO:0048583
|
regulation of response to stimulus
|
1.35
|
3.06e-08
|
GO:0051173
|
positive regulation of nitrogen compound metabolic process
|
1.12
|
4.88e-08
|
GO:0043170
|
macromolecule metabolic process
|
1.14
|
5.01e-08
|
GO:0019222
|
regulation of metabolic process
|
1.39
|
7.47e-08
|
GO:0009887
|
organ morphogenesis
|
1.30
|
8.60e-08
|
GO:0009892
|
negative regulation of metabolic process
|
1.34
|
1.06e-07
|
GO:0045935
|
positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
1.38
|
1.17e-07
|
GO:0032989
|
cellular component morphogenesis
|
1.38
|
1.22e-07
|
GO:0045893
|
positive regulation of transcription, DNA-dependent
|
1.36
|
1.75e-07
|
GO:0010628
|
positive regulation of gene expression
|
1.31
|
1.84e-07
|
GO:0006351
|
transcription, DNA-dependent
|
1.36
|
2.01e-07
|
GO:0031327
|
negative regulation of cellular biosynthetic process
|
1.76
|
2.26e-07
|
GO:0045165
|
cell fate commitment
|
1.35
|
2.50e-07
|
GO:0009890
|
negative regulation of biosynthetic process
|
1.15
|
2.65e-07
|
GO:0060255
|
regulation of macromolecule metabolic process
|
1.38
|
2.68e-07
|
GO:0000902
|
cell morphogenesis
|
1.42
|
2.82e-07
|
GO:0031175
|
neuron projection development
|
1.13
|
2.89e-07
|
GO:0051716
|
cellular response to stimulus
|
1.36
|
4.02e-07
|
GO:0051254
|
positive regulation of RNA metabolic process
|
1.20
|
6.12e-07
|
GO:0048513
|
organ development
|
1.30
|
7.79e-07
|
GO:0050793
|
regulation of developmental process
|
1.35
|
8.45e-07
|
GO:0010558
|
negative regulation of macromolecule biosynthetic process
|
1.36
|
9.39e-07
|
GO:2000113
|
negative regulation of cellular macromolecule biosynthetic process
|
1.34
|
1.28e-06
|
GO:0045595
|
regulation of cell differentiation
|
1.29
|
1.36e-06
|
GO:0010605
|
negative regulation of macromolecule metabolic process
|
1.30
|
1.69e-06
|
GO:0031328
|
positive regulation of cellular biosynthetic process
|
1.26
|
1.73e-06
|
GO:0010604
|
positive regulation of macromolecule metabolic process
|
1.25
|
1.96e-06
|
GO:0031325
|
positive regulation of cellular metabolic process
|
1.46
|
2.04e-06
|
GO:0048598
|
embryonic morphogenesis
|
1.12
|
2.29e-06
|
GO:0044260
|
cellular macromolecule metabolic process
|
1.32
|
2.44e-06
|
GO:0010557
|
positive regulation of macromolecule biosynthetic process
|
1.16
|
3.75e-06
|
GO:0031326
|
regulation of cellular biosynthetic process
|
1.42
|
3.82e-06
|
GO:0048667
|
cell morphogenesis involved in neuron differentiation
|
1.44
|
3.85e-06
|
GO:0000122
|
negative regulation of transcription from RNA polymerase II promoter
|
1.24
|
4.21e-06
|
GO:0009893
|
positive regulation of metabolic process
|
1.29
|
4.91e-06
|
GO:0009891
|
positive regulation of biosynthetic process
|
1.37
|
5.13e-06
|
GO:0045892
|
negative regulation of transcription, DNA-dependent
|
1.16
|
5.28e-06
|
GO:0009889
|
regulation of biosynthetic process
|
1.24
|
5.45e-06
|
GO:0051239
|
regulation of multicellular organismal process
|
1.37
|
5.70e-06
|
GO:0051253
|
negative regulation of RNA metabolic process
|
1.56
|
6.01e-06
|
GO:0003002
|
regionalization
|
1.31
|
6.68e-06
|
GO:2000026
|
regulation of multicellular organismal development
|
1.34
|
6.68e-06
|
GO:0030030
|
cell projection organization
|
1.27
|
1.01e-05
|
GO:0032774
|
RNA biosynthetic process
|
1.09
|
1.04e-05
|
GO:0044238
|
primary metabolic process
|
1.37
|
1.08e-05
|
GO:0007169
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
1.16
|
1.12e-05
|
GO:2000112
|
regulation of cellular macromolecule biosynthetic process
|
1.49
|
1.22e-05
|
GO:0048729
|
tissue morphogenesis
|
1.15
|
1.33e-05
|
GO:0051171
|
regulation of nitrogen compound metabolic process
|
1.44
|
1.56e-05
|
GO:0043009
|
chordate embryonic development
|
1.34
|
1.67e-05
|
GO:0051172
|
negative regulation of nitrogen compound metabolic process
|
1.34
|
1.77e-05
|
GO:0045934
|
negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
1.45
|
1.81e-05
|
GO:0007389
|
pattern specification process
|
1.31
|
1.95e-05
|
GO:0009790
|
embryo development
|
1.50
|
1.97e-05
|
GO:0035295
|
tube development
|
1.39
|
2.38e-05
|
GO:0048812
|
neuron projection morphogenesis
|
1.43
|
2.48e-05
|
GO:0009792
|
embryo development ending in birth or egg hatching
|
1.40
|
2.55e-05
|
GO:0007409
|
axonogenesis
|
1.16
|
2.61e-05
|
GO:0010556
|
regulation of macromolecule biosynthetic process
|
1.33
|
3.16e-05
|
GO:0010629
|
negative regulation of gene expression
|
1.15
|
3.34e-05
|
GO:0019219
|
regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
1.47
|
3.45e-05
|
GO:0051130
|
positive regulation of cellular component organization
|
1.37
|
4.13e-05
|
GO:0045944
|
positive regulation of transcription from RNA polymerase II promoter
|
1.13
|
4.93e-05
|
GO:0016043
|
cellular component organization
|
1.49
|
6.44e-05
|
GO:0001568
|
blood vessel development
|
1.18
|
9.64e-05
|
GO:0007166
|
cell surface receptor linked signaling pathway
|
1.15
|
1.03e-04
|
GO:0071842
|
cellular component organization at cellular level
|
1.15
|
1.20e-04
|
GO:0010468
|
regulation of gene expression
|
1.18
|
1.32e-04
|
GO:0006464
|
protein modification process
|
1.25
|
1.40e-04
|
GO:0032879
|
regulation of localization
|
1.07
|
1.67e-04
|
GO:0008152
|
metabolic process
|
1.61
|
1.98e-04
|
GO:0009952
|
anterior/posterior pattern formation
|
1.36
|
2.02e-04
|
GO:0048646
|
anatomical structure formation involved in morphogenesis
|
1.15
|
2.13e-04
|
GO:0051252
|
regulation of RNA metabolic process
|
1.34
|
2.68e-04
|
GO:0048858
|
cell projection morphogenesis
|
1.26
|
2.71e-04
|
GO:0016265
|
death
|
1.34
|
2.78e-04
|
GO:0007417
|
central nervous system development
|
1.26
|
3.20e-04
|
GO:0008219
|
cell death
|
1.12
|
3.32e-04
|
GO:0071840
|
cellular component organization or biogenesis
|
1.43
|
3.65e-04
|
GO:0060284
|
regulation of cell development
|
1.34
|
3.78e-04
|
GO:0032990
|
cell part morphogenesis
|
1.15
|
3.83e-04
|
GO:0006355
|
regulation of transcription, DNA-dependent
|
1.43
|
4.01e-04
|
GO:0022603
|
regulation of anatomical structure morphogenesis
|
1.08
|
5.00e-04
|
GO:0044237
|
cellular metabolic process
|
1.44
|
6.32e-04
|
GO:0001944
|
vasculature development
|
1.48
|
7.08e-04
|
GO:0048568
|
embryonic organ development
|
1.77
|
7.33e-04
|
GO:0030326
|
embryonic limb morphogenesis
|
1.77
|
7.33e-04
|
GO:0035113
|
embryonic appendage morphogenesis
|
1.89
|
7.61e-04
|
GO:0009953
|
dorsal/ventral pattern formation
|
1.13
|
1.43e-03
|
GO:0071841
|
cellular component organization or biogenesis at cellular level
|
1.12
|
2.29e-03
|
GO:0019538
|
protein metabolic process
|
1.26
|
3.42e-03
|
GO:0019220
|
regulation of phosphate metabolic process
|
1.26
|
3.42e-03
|
GO:0051174
|
regulation of phosphorus metabolic process
|
1.49
|
3.74e-03
|
GO:0044087
|
regulation of cellular component biogenesis
|
1.33
|
3.97e-03
|
GO:0051094
|
positive regulation of developmental process
|
1.32
|
4.03e-03
|
GO:0072358
|
cardiovascular system development
|
1.32
|
4.03e-03
|
GO:0072359
|
circulatory system development
|
1.38
|
4.08e-03
|
GO:0045597
|
positive regulation of cell differentiation
|
1.21
|
4.51e-03
|
GO:0010646
|
regulation of cell communication
|
1.67
|
4.76e-03
|
GO:0035107
|
appendage morphogenesis
|
1.67
|
4.76e-03
|
GO:0035108
|
limb morphogenesis
|
1.41
|
4.82e-03
|
GO:0061061
|
muscle structure development
|
1.25
|
5.11e-03
|
GO:0006915
|
apoptosis
|
1.50
|
5.49e-03
|
GO:0035239
|
tube morphogenesis
|
1.69
|
5.63e-03
|
GO:0003007
|
heart morphogenesis
|
1.37
|
5.70e-03
|
GO:0007411
|
axon guidance
|
1.49
|
5.85e-03
|
GO:0048732
|
gland development
|
1.33
|
6.23e-03
|
GO:0032583
|
regulation of gene-specific transcription
|
1.55
|
6.31e-03
|
GO:0060562
|
epithelial tube morphogenesis
|
1.13
|
6.34e-03
|
GO:0044267
|
cellular protein metabolic process
|
1.45
|
6.34e-03
|
GO:0051129
|
negative regulation of cellular component organization
|
1.43
|
6.45e-03
|
GO:0000165
|
MAPKKK cascade
|
1.35
|
7.63e-03
|
GO:0010551
|
regulation of gene-specific transcription from RNA polymerase II promoter
|
1.45
|
7.63e-03
|
GO:0002009
|
morphogenesis of an epithelium
|
1.15
|
1.03e-02
|
GO:0043412
|
macromolecule modification
|
1.55
|
1.08e-02
|
GO:0001655
|
urogenital system development
|
1.25
|
1.08e-02
|
GO:0042325
|
regulation of phosphorylation
|
1.22
|
1.10e-02
|
GO:0009888
|
tissue development
|
1.63
|
1.11e-02
|
GO:0048736
|
appendage development
|
1.63
|
1.11e-02
|
GO:0060173
|
limb development
|
1.24
|
1.12e-02
|
GO:0012501
|
programmed cell death
|
1.20
|
1.22e-02
|
GO:0010941
|
regulation of cell death
|
1.20
|
1.31e-02
|
GO:0032268
|
regulation of cellular protein metabolic process
|
1.38
|
1.69e-02
|
GO:0030029
|
actin filament-based process
|
1.62
|
1.71e-02
|
GO:0072001
|
renal system development
|
1.20
|
1.79e-02
|
GO:0043067
|
regulation of programmed cell death
|
1.41
|
2.10e-02
|
GO:0030036
|
actin cytoskeleton organization
|
1.17
|
2.12e-02
|
GO:0035556
|
intracellular signal transduction
|
1.15
|
2.19e-02
|
GO:0009059
|
macromolecule biosynthetic process
|
1.71
|
2.39e-02
|
GO:0048706
|
embryonic skeletal system development
|
1.22
|
2.44e-02
|
GO:0031399
|
regulation of protein modification process
|
1.14
|
2.85e-02
|
GO:0010467
|
gene expression
|
1.15
|
2.96e-02
|
GO:0034645
|
cellular macromolecule biosynthetic process
|
1.35
|
3.03e-02
|
GO:0001501
|
skeletal system development
|
1.55
|
3.04e-02
|
GO:0048705
|
skeletal system morphogenesis
|
1.45
|
3.04e-02
|
GO:0007517
|
muscle organ development
|
1.56
|
3.30e-02
|
GO:0022604
|
regulation of cell morphogenesis
|
1.15
|
3.34e-02
|
GO:0016070
|
RNA metabolic process
|
1.25
|
3.42e-02
|
GO:0001932
|
regulation of protein phosphorylation
|
1.19
|
3.54e-02
|
GO:0007154
|
cell communication
|
1.19
|
3.98e-02
|
GO:0051246
|
regulation of protein metabolic process
|
1.19
|
4.47e-02
|
GO:0042981
|
regulation of apoptosis
|
1.42
|
4.52e-02
|
GO:0048514
|
blood vessel morphogenesis
|
1.60
|
4.92e-02
|
GO:0001822
|
kidney development
|
1.43
|
4.97e-02
|
GO:0001701
|
in utero embryonic development
|